Tech Company Financing Transactions

EnVivo Pharmaceuticals Funding Round

F-Prime Capital joined a $65 million funding round for EnVivo Pharmaceuticals. The round was announced on 10/31/2008.

Transaction Overview

Announced On
10/31/2008
Transaction Type
Venture Equity
Amount
$65,000,000
Round
Undisclosed
Investors

F-Prime Capital (Stephen Knight)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
500 Arsenal St.
Watertown, MA 02472
USA
Email Address
Overview
EnVivo is a biopharmaceutical company dedicated to discovering and developing drugs for central nervous system (CNS) disorders. CNS disorders account for more hospitalizations, long-term care, and chronic suffering than nearly all other diseases combined.
Profile
EnVivo Pharmaceuticals LinkedIn Company Profile
Social Media
EnVivo Pharmaceuticals Company Twitter Account
Company News
EnVivo Pharmaceuticals News
Facebook
EnVivo Pharmaceuticals on Facebook
YouTube
EnVivo Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Deborah Dunsire
  Deborah Dunsire LinkedIn Profile  Deborah Dunsire Twitter Account  Deborah Dunsire News  Deborah Dunsire on Facebook
Chief Medical Officer
Dana Hilt
  Dana Hilt LinkedIn Profile  Dana Hilt Twitter Account  Dana Hilt News  Dana Hilt on Facebook
Chief Scientific Officer
Gerhard Koenig
  Gerhard Koenig LinkedIn Profile  Gerhard Koenig Twitter Account  Gerhard Koenig News  Gerhard Koenig on Facebook
VP - Bus. Development
Chris Burnley
  Chris Burnley LinkedIn Profile  Chris Burnley Twitter Account  Chris Burnley News  Chris Burnley on Facebook
VP - General Counsel
Maiken Keson-Brookes
  Maiken Keson-Brookes LinkedIn Profile  Maiken Keson-Brookes Twitter Account  Maiken Keson-Brookes News  Maiken Keson-Brookes on Facebook
VP - Human Resources
Elaine Ouellette
  Elaine Ouellette LinkedIn Profile  Elaine Ouellette Twitter Account  Elaine Ouellette News  Elaine Ouellette on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/31/2008: Novariant venture capital transaction
Next: 10/31/2008: Nanostim venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary